The Tool That Helped Us Decode Alzheimer's Genetics
Imagine you've found a treasure map. But the map is written in code. You need a decoder ring to understand it.
That's what functional annotation tools are for genetic research. And FUMA is one of the best.
What Is FUMA?
FUMA (Functional Mapping and Annotation of GWAS) is a comprehensive functional annotation tool:
| Feature | What It Does |
|---|---|
| SNP2GENE | Annotates GWAS results |
| GENE2FUNC | Analyzes gene sets |
| Visualization | Generates plots and tables |
| Integration | Combines multiple data types |
FUMA is your decoder ring for Alzheimer's genetics.
What FUMA Does
1. Positional Mapping
| Function | What It Does |
|---|---|
| SNP proximity | Identifies genes near SNPs |
| Gene boundaries | Maps SNPs to genes |
| Distance threshold | Default ±10 kb |
2. eQTL Mapping
| Function | What It Does |
|---|---|
| Expression effects | Identifies SNPs that affect expression |
| Tissue specificity | Identifies tissue-specific effects |
| GTEx data | Uses GTEx v8 data |
3. Chromatin Interaction Mapping
| Function | What It Does |
|---|---|
| 3D structure | Identifies chromatin interactions |
| Hi-C data | Uses H1-hESC and IMR90 cell lines |
| Regulatory elements | Identifies enhancer-promoter interactions |
4. Functional Annotation
| Function | What It Does |
|---|---|
| CADD scores | Predicts variant impact |
| RegulomeDB | Regulatory potential |
| Chromatin states | Tissue-specific activity |
How We Used FUMA
Step 1: Input
We provided:
| Input | What It Was |
|---|---|
| GWAS summary statistics | FinnGen Alzheimer's data |
| Lead SNPs | Three genome-wide significant variants |
| LD reference | 1000 Genomes Phase 3 European |
Step 2: Annotation
FUMA performed:
| Annotation | What It Found |
|---|---|
| Positional mapping | APOE, TOMM40, APOC1, PVRL2 |
| eQTL mapping | No significant eQTLs |
| Chromatin interaction | No significant interactions |
| Functional annotation | CADD scores, RegulomeDB, chromatin states |
Step 3: Output
FUMA generated:
| Output | What It Showed |
|---|---|
| Gene prioritization | APOE, TOMM40, APOC1, PVRL2 |
| Variant annotation | 75.1% non-coding |
| Regional plots | Chromosome 19 locus |
| LD structure | r² ≥ 0.6 with lead SNP |
What FUMA Revealed
1. APOE, TOMM40, APOC1, and PVRL2
| Gene | Function | Significance |
|---|---|---|
| APOE | Lipid transport, amyloid clearance | Lead gene |
| TOMM40 | Mitochondrial function | Equivalent to APOE |
| APOC1 | Lipid metabolism | Equivalent to APOE |
| PVRL2 | Cell adhesion | Lower but significant |
The chromosome 19 locus contains multiple genes, not just APOE.
2. Non-Coding Variants
| Category | Percentage |
|---|---|
| Intergenic | 43.8% |
| Intronic | 31.3% |
| Total non-coding | 75.1% |
Most variants are in non-coding regions.
3. LD Structure
| Observation | Implication |
|---|---|
| r² ≥ 0.6 with lead SNP | Multiple variants are correlated |
| Shared haplotype | Variants are inherited together |
| Gene-rich interval | Multiple genes in the locus |
What We Did NOT Find
No Significant eQTLs
| Finding | Implication |
|---|---|
| No eQTL evidence | Variants don't show clear expression effects |
| Maybe context-dependent | Effects may depend on cell type or state |
| Need experimental validation | Functional studies needed |
No Significant Chromatin Interactions
| Finding | Implication |
|---|---|
| No chromatin interaction evidence | Variants don't show clear 3D interactions |
| Maybe context-dependent | Interactions may depend on cell type |
| Need experimental validation | 3D studies needed |
The Limitations of FUMA
1. Context Dependence
| Limitation | Why It Matters |
|---|---|
| Tissue-specific | Effects may only appear in certain tissues |
| Cell-state dependent | Effects may depend on cellular state |
| Dynamic | Effects may change over time |
2. Data Quality
| Limitation | Why It Matters |
|---|---|
| Reference data | Depends on quality of reference datasets |
| Sample size | Limited by available data |
| Ancestry | Reference data is mostly European |
3. Prediction vs. Reality
| Limitation | Why It Matters |
|---|---|
| Predictions | FUMA makes predictions, not measurements |
| Experimental validation needed | Predictions need confirmation |
| False positives | Some predictions may be wrong |
The Bottom Line
- FUMA is a powerful functional annotation tool
- It identified APOE, TOMM40, APOC1, and PVRL2 as key genes
- Most variants are non-coding (75.1%)
- No significant eQTLs or chromatin interactions were found
- Experimental validation is needed for functional confirmation
FUMA helped us understand our Alzheimer's genetics—but it's just the beginning.
Key Takeaways
| Finding | Implication |
|---|---|
| APOE, TOMM40, APOC1, PVRL2 | Key genes identified |
| 75.1% non-coding | Regulatory variation is important |
| No eQTL evidence | Expression effects may be context-dependent |
| Experimental validation needed | Confirm functional effects |
What do you think?
👍
😂
❤️
😮
😡
😢
0 Responses
Osaghale L, Beshiru A, Subhan U. (2026). Replication-guided functional genomic prioritization of regulatory risk variants in Alzheimer's disease. Gene Reports. 44: 102551.
Code Availability: https://github.com/Oselin1988/GWAS_AD
Next post: "eQTL Analysis: The Search for Expression Effects in Alzheimer's" — Coming soon!
← Back to Blog Home